Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
38.00
+0.19 (0.50%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Cytokinetics Employees
Cytokinetics had 498 employees as of December 31, 2024. The number of employees increased by 75 or 17.73% compared to the previous year.
Employees
498
Change (1Y)
75
Growth (1Y)
17.73%
Revenue / Employee
$37,096
Profits / Employee
-$1,183,787
Market Cap
4.50B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
CYTK News
- 1 day ago - Cytokinetics to Announce First Quarter Results on May 6, 2025 - GlobeNewsWire
- 6 days ago - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community - GlobeNewsWire
- 5 weeks ago - Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo - GlobeNewsWire
- 5 weeks ago - Cytokinetics Nears Approval: 'Buy' The New Potential Cardiology Franchise With Aficamten - Seeking Alpha
- 7 weeks ago - Cytokinetics to Participate in March Investor Conferences - GlobeNewsWire
- 7 weeks ago - Cytokinetics, Incorporated (CYTK) Q4 2024 Earnings Call Transcript - Seeking Alpha